Indrayani Biotech logo

Indrayani Biotech financials and balance sheet

BSE: 526445Agricultural Food & other ProductsSmall Cap

Last close ₹8.34down ₹0.43 (4.90%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹8.77.

52-week range of traded prices to 23 Oct 2026
₹6.10Low, 19 Mar 2026₹16.47High, 6 Nov 2025
Market cap
₹38 Cr3,322nd largest listed
P/E
Owners' profit not stated
P/B
0.5
Dividend yield
Nonein the last 12 months
ROCE
1.9%
Debt to equity
1.26
Volume, BSE
19,910

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Indrayani Biotech annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹74 Cr, year to Mar 2023A loss in 3 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 249.6% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue22
  2. Materials and goods−11
  3. Employee costs−7.0
  4. Other expenses−2.7
  5. Operating profit1.6
  6. Depreciation−0.6
  7. Other income+4.2
  8. One-off items0.0
  9. Finance costs−3.9
  10. Profit before tax1.2
  11. Tax−0.5
  12. Net profit0.7

What the company owns

  • Plant, investments and other assets₹104 Cr
  • Receivables₹16 Cr
  • Inventory₹2 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹59 Cr
  • Net worth₹56 Cr
  • Other liabilities₹5 Cr
  • Owed to suppliers₹1 Cr

Profit and loss

Standalone, ₹ crore, years to March.Indrayani Biotech quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 15 JunMar 2020Filed 19 JunMar 2021Filed 9 JulMar 2022Filed 10 JunMar 2023Filed 15 JunMar 2024Filed 21 JunMar 2025Filed 14 JunMar 2026Filed 22 Sep
Revenue from operations––47.049.921.058.074.562.337.821.9
––44.947.125.751.865.856.732.320.3
Materials and goods bought––30.032.515.839.741.535.214.810.7
Employee costs––11.711.45.79.017.515.713.27.0
Other expenses––3.23.34.23.16.85.84.32.7
Operating profit before depreciation––2.12.8−4.76.28.75.75.51.6
Operating margin––4.5%5.6%−22.3%10.7%11.6%9.1%14.5%7.2%
Materials, % of revenue––63.8%65.1%75.0%68.5%55.7%56.4%39.1%48.6%
Employee costs, % of revenue––25.0%22.7%27.2%15.5%23.5%25.2%35.0%32.0%
Other expenses, % of revenue––6.8%6.6%20.1%5.3%9.2%9.3%11.3%12.1%
Depreciation and amortisation––1.11.00.40.30.91.41.00.6
Operating profit after depreciation––1.01.8−5.15.97.74.24.50.9
Other income––0.50.20.30.20.63.63.54.2
Finance costs–0.01.11.22.01.92.84.87.33.9
Profit before one-off items and tax−0.1−0.10.40.8−6.84.25.63.00.61.2
One-off items––0.00.0−4.10.0−0.50.00.00.0
Profit before tax−0.1−0.10.40.8−10.94.25.13.00.61.2
––0.30.00.00.00.01.6−0.80.5
Net profit−0.1−0.10.00.8−10.94.25.11.51.40.7
Net margin––0.1%1.6%−51.8%7.3%6.8%2.3%3.8%3.2%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2018: the statement does not state its revenue or depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 15 JunMar 2020Filed 19 JunMar 2021Filed 9 JulMar 2022Filed 10 JunMar 2023Filed 15 JunMar 2024Filed 21 JunMar 2025Filed 14 JunMar 2026Filed 22 Sep
3031202451555556
Share capital3434343443464646
Reserves−4−3−14−10891010
1414151735596259
1314121833526139
778716201427
Total assets50514049100126131122
3032302951555048
2119102049728174
Net debt1312151535596259
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2020Filed 19 JunMar 2021Filed 9 JulMar 2022Filed 10 JunMar 2023Filed 15 JunMar 2024Filed 21 JunMar 2025Filed 14 JunMar 2026Filed 22 Sep
6.00.53.58.426.117.4−14.1
6.0−1.43.58.426.110.0−18.0
3.06.9−3.0−0.816.88.5−19.9
Receivables0.92.3−8.1−3.3−1.41.10.4
Inventories3.54.0−0.3−0.5−0.10.2−0.1
Payables1.4−2.83.0−4.91.25.8−7.0
Other working capital−2.73.52.47.817.11.3−13.2
Interest paid0.02.00.00.00.07.33.9
Capital spending3.50.40.11.96.30.90.1
Free cash flow2.50.13.46.519.716.5−14.2
−3.7−0.60.6−14.1−7.2−1.31.4
−1.3−0.7−3.24.9−19.2−16.212.7
Dividends paid0.00.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.00.0
Shares issued0.00.00.023.34.60.00.0
Net change in cash1.0−0.80.8−0.8−0.4−0.20.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018 and Mar 2019.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 15 JunMar 2020Filed 19 JunMar 2021Filed 9 JulMar 2022Filed 10 JunMar 2023Filed 15 JunMar 2024Filed 21 JunMar 2025Filed 14 JunMar 2026Filed 22 Sep
Earnings per share−₹0.03−₹0.34₹0.01₹0.24−₹3.18₹1.23₹1.48₹0.32–₹0.25
Diluted earnings per share−₹0.03−₹0.34₹0.01₹0.24−₹3.18₹1.23₹1.20₹0.32–₹0.25
Book value per share––₹8.77₹84.70₹5.83₹7.06₹14.94₹11.97₹12.15₹12.30
Shareholder yield–––0.0%0.0%0.0%−12.0%−2.1%0.0%0.0%
Market cap at the year end (₹ crore)2233221041932246533
Earnings per share is left blank for the year to Mar 2025: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Standalone, years to March.Indrayani Biotech PE ratio and valuation

RatioMar 2019Filed 15 JunMar 2020Filed 19 JunMar 2021Filed 9 JulMar 2022Filed 10 JunMar 2023Filed 15 JunMar 2024Filed 21 JunMar 2025Filed 14 JunMar 2026Filed 22 Sep
Revenue growth–6.2%−57.9%176.0%28.4%−16.3%−39.4%−42.0%
Operating profit growth–31.4%––38.9%−34.5%−3.3%−71.1%
Net profit growth–1,602.8%––19.7%−71.2%−0.8%−51.6%
Earnings per share growth–1,614.3%––20.3%−78.4%––
0.2%2.7%−42.9%19.2%13.4%2.8%2.6%1.3%
–2.5 pts−45.5 pts62.0 pts−5.7 pts−10.7 pts−0.1 pts−1.4 pts
From the net margin–2.4 pts−87.6 pts48.9 pts−1.3 pts−8.8 pts1.8 pts−0.4 pts
From asset turnover–0.1 pts45.2 pts11.0 pts−4.2 pts−2.1 pts−2.1 pts−0.9 pts
From borrowing–0.0 pts−3.1 pts2.1 pts−0.2 pts0.2 pts0.2 pts0.0 pts
Return on capital employed2.3%4.0%−14.4%14.4%8.9%3.7%3.8%0.8%
Cash conversion–737.0%–82.4%166.0%1,790.1%1,199.8%−2,015.6%
Interest cover0.91.5–3.12.80.90.60.2
Debt to equity0.460.450.770.690.691.091.111.06
Receivable days6252838180103159268
Inventory days10457251316204260
Payable days59707959142821147
Cash conversion cycle, days1063829348295−11282
Working capital days1088077632023766481,131
Asset turnover0.940.980.461.300.990.550.290.17
Assets per rupee of net worth1.671.671.802.021.992.142.342.27
Sales per rupee of plant3.353.691.865.053.733.502.941.82
Capital spending to depreciation–3.460.950.182.044.380.830.21
Plant being built, % of plant in use76.0%100.5%121.7%115.0%63.7%101.1%141.1%150.1%
Interest cover is left blank for the year to Mar 2021: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
0.6%
Cash from operations against operating profit
−892.1%
Measure5 years3 years
Revenue growth, yearly rate0.8%−33.5%
Profit growth, yearly rate–−48.3%
Return on equity, average7.8%2.2%
Return on capital employed, average6.3%2.8%
Operating margin, average10.6%10.3%
Net margin, average4.7%3.1%
Asset turnover, average0.660.34
Cash conversion cycle, days, average97122
Interest cover, average1.50.6
Debt to equity, average0.931.09

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations41.229.3−14.1
Cash from investing−20.7−7.21.4
Cash from financing−21.1−22.812.7
Capital spending9.37.30.1
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash27.94.60.0
Borrowings raised21.118.113.0
Borrowings repaid5.84.53.6

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––38––––
Beneish M-scorePublished threshold −1.78–−2.94−3.52–––––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–−2.95−23.74–––––
Receivables growth less revenue growthOur threshold 0 percentage points–−17.4325.59–––––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−48.89−27.15–––––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–10.37−24.78–––––
Assets under construction, years of additionsOur threshold 2 years of additions–26.35––––––
Effective tax ratePublished threshold 17.16 per cent86.910.00––––––
A threshold marked as ours has no published figure; it is the line we read the check against.